Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
OCX.OQ - OncoCyte Corp
Q4 2024 OncoCyte Corp Earnings Call
Mar 24, 2025 / 09:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome, everyone, and thank you for joining us to discuss OncoSite's 4th quarter 2024 results.
If you have not seen today's shareholder letter, please visit OncoSite.
Investor relations page at investors. OncoSite.com. Today's prepared remarks build upon the information already shared in this robust letter.
Joining us today are OncoSite President and CEO Josh Riggs, Chief Science Officer Ecky Schutz, and CFO Andrea James.
We also have our analysts with us as panelists. After our prepared remarks, our analysts may ask questions.
Attendees may also type questions into the Q&A.
Before turning the call over to Josh Riggs, I like to go over our safe harbor.
The company will make